Benatti Luca
SEC CIK 1613842 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Dir | 39.2K | — | $173.5K | 2 | 2024-10-23 | 2025-12-26 |
Most active insiders at QNCX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Benatti Luca | Dir | — | $173.5K |
| 2 | Hannah Brendan | COO, CCO, CBO | — | — |
| 3 | Thye Dirk | CEO, CMO, Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2024-10-23 | QNCX | Quince Therapeutics, Inc. | Benatti Luca | Dir | J - Other | — | +8,918 | 89.2K | +11% | — | |
| 2025-12-29 | 2025-12-26 | QNCX | Quince Therapeutics, Inc. | Benatti Luca | Dir | S - Sale | $3.47 | -50.0K | 39.2K | -56% | -$173.5K |
Purchase Sale Sale after option exercise All abbreviations